Abeona Therapeutics Inc vs InMode Ltd — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while InMode Ltd trades at $15.16 (market cap $872.08M). The key difference: InMode Ltd is far larger — about 2.1× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, InMode Ltd nearer its low. Which is the better fit depends on your goals.
| ABEO | INMD | |
|---|---|---|
Market Cap | $421.19M | $872.08M |
Sector | Health | Technology |
52-Week High | $7.45 | $16.62 |
52-Week Low | $4.17 | $12.76 |
Enterprise Value | $276.10M | $375.42M |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →